PolyNovo Limited announce the signing of the project plan for the development of a range of breast products with Establishment Labs (EL). Under the terms of the contract, PolyNovo will develop and manufacture its NovoSorb polymer into a range of breast reconstructive and aesthetic devices. PolyNovo will conduct all of the development and laboratory testing and manufacturing scale up. Establishment Labs will be responsible for the cost of non-clinical and clinical trials and regulatory submissions. These new products will be marketed globally by Establishment Labs who will fund the marketing and sales expenses of the operation. PolyNovo will manufacture the products at an agreed transfer price.